Clinical trials have revealed a breakthrough treatment that slows Parkinson's disease progression by half. The therapy targets the underlying brain changes rather than just managing symptoms.
"For the first time, we can actually slow down this disease," said the neurologist leading the trial. "Patients are maintaining their quality of life for much longer."
“The therapy targets the underlying brain changes rather than just managing symptoms.”
The treatment is now being fast-tracked for approval, with regulators recognizing the urgent need for better Parkinson's therapies as the global population ages.
How did this story make you feel?
